Bayer Competitors and Similar CompaniesClear all
Bayer's competitors and similar companies include Astellas Pharma, Roche, Novartis and Johnson & Johnson.
 Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Johnson & Johnson Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. | |||
Founding Date | Founding Date 1863 | Founding Date 1923 | Founding Date 1896 | Founding Date 1996 | Founding Date 1886 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New Brunswick, US HQ Buenos Aires, AR Sydney, AU Vienna, AT Minsk, BY Beerse, BE Sofia, BG see more | ||
Employees | Employees 88,5021% decrease | Employees 14,754 | Employees 103,249 | Employees 75,883 | Employees 138,1005% increase |
Valuation ($) | Valuation ($) 27.1 b | Valuation ($) 20.8 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 396.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) ¥2.1t (FY, 2026) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $94.2b (FY, 2025) |
Cost of goods | Cost of goods €14b (FY, 2025) | Cost of goods ¥213.8b (FY, 2026) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $30.3b (FY, 2025) |
Gross profit | Gross profit €32.5b (FY, 2025) | Gross profit ¥2t (FY, 2026) | Gross profit CHF50.5b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $63.9b (FY, 2025) |
Net income | Net income (€3.6b) (FY, 2025) | Net income ¥291.6b (FY, 2026) | Net income CHF13.8b (FY, 2025) | Net income $14b (FY, 2025) | Net income $26.8b (FY, 2025) |
Operating ⚠ | |||||
Patients | Patients N/A | Patients N/A | Patients 22.8 m (FY, 2023) | Patients 10 m (FY, 2022) | Patients N/A |
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 4 (Oct, 2020) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 27 (FY, 2021) | Phase III Trials Products (Oncology) N/A |
Funding | |||||
Total funding raised | Total funding raised $ 3.5b | Total funding raised N/A | Total funding raised $ 7.8b | Total funding raised $ 6.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Astellas Pharma
HQ
Tokyo, JP
Employees
14,754
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyJohnson & Johnson
HQ
New Brunswick, US
Employees
138,100↑ 5% increase
Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field.
View company